132 related articles for article (PubMed ID: 31140872)
1. Renal function and oral anticoagulant treatment of incident non-valvular atrial fibrillation: a retrospective study.
Ramagopalan SV; Stamp E; Sammon CJ; Besford M; Carroll R; Mehmud F; Alikhan R
Future Cardiol; 2019 Jul; 15(4):301-309. PubMed ID: 31140872
[No Abstract] [Full Text] [Related]
2. Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis.
Coleman CI; Kreutz R; Sood NA; Bunz TJ; Eriksson D; Meinecke AK; Baker WL
Am J Med; 2019 Sep; 132(9):1078-1083. PubMed ID: 31054829
[TBL] [Abstract][Full Text] [Related]
3. Estimated glomerular filtration rate within the normal or mildly impaired range and incident non-valvular atrial fibrillation: Results from a population-based cohort study.
Eisen A; Haim M; Hoshen M; Balicer RD; Reges O; Leibowitz M; Iakobishvili Z; Hasdai D
Eur J Prev Cardiol; 2017 Jan; 24(2):213-222. PubMed ID: 27798368
[TBL] [Abstract][Full Text] [Related]
4. Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study.
Martinez C; Katholing A; Wallenhorst C; Freedman SB
Thromb Haemost; 2016 Jan; 115(1):31-9. PubMed ID: 26246112
[TBL] [Abstract][Full Text] [Related]
5. Oral Anticoagulation in Chronic Kidney Disease and Atrial Fibrillation.
Heine GH; Brandenburg V; Schirmer SH
Dtsch Arztebl Int; 2018 Apr; 115(17):287-294. PubMed ID: 29789105
[TBL] [Abstract][Full Text] [Related]
6. Stroke prevention in atrial fibrillation patients with chronic kidney disease.
Hart RG; Eikelboom JW; Brimble KS; McMurtry MS; Ingram AJ
Can J Cardiol; 2013 Jul; 29(7 Suppl):S71-8. PubMed ID: 23790601
[TBL] [Abstract][Full Text] [Related]
7. Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry.
Deng H; Shantsila A; Xue Y; Bai Y; Guo P; Potpara TS; Zhan X; Fang X; Liao H; Wu S; Lip GYH
Arch Cardiovasc Dis; 2019; 112(6-7):420-429. PubMed ID: 31133543
[TBL] [Abstract][Full Text] [Related]
8. Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care.
Kumar S; de Lusignan S; McGovern A; Correa A; Hriskova M; Gatenby P; Jones S; Goldsmith D; Camm AJ
BMJ; 2018 Feb; 360():k342. PubMed ID: 29444881
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of renal dysfunction according to the type of atrial fibrillation and anticoagulation treatment in patients who attended primary care in Spain.
Barrios V; Escobar C; Calderón A; Zamorano JL
Future Cardiol; 2014 Mar; 10(2):215-20. PubMed ID: 24762248
[TBL] [Abstract][Full Text] [Related]
10. Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.
Szummer K; Gasparini A; Eliasson S; Ärnlöv J; Qureshi AR; Bárány P; Evans M; Friberg L; Carrero JJ
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28249846
[TBL] [Abstract][Full Text] [Related]
11. Treatment and persistence with oral anticoagulants among newly diagnosed patients with non-valvular atrial fibrillation: a retrospective observational study in a US commercially insured and Medicare Advantage population.
Willey V; Franchino-Elder J; Fu AC; Wang C; Sander S; Tan H; Kraft E; Jain R
BMJ Open; 2018 Jun; 8(6):e020676. PubMed ID: 29961012
[TBL] [Abstract][Full Text] [Related]
12. Utilization of Standard and Target-Specific Oral Anticoagulants Among Adults in the United Kingdom With Incident Atrial Fibrillation.
Durham TA; Hassmiller Lich K; Viera AJ; Fine JP; Mukherjee J; Weinberger M; Dusetzina SB
Am J Cardiol; 2017 Nov; 120(10):1820-1829. PubMed ID: 28867127
[TBL] [Abstract][Full Text] [Related]
13. Which anticoagulants should be used for stroke prevention in non-valvular atrial fibrillation and severe chronic kidney disease?
Kalra PA; Burlacu A; Ferro CJ; Covic A
Curr Opin Nephrol Hypertens; 2018 Nov; 27(6):420-425. PubMed ID: 30020140
[TBL] [Abstract][Full Text] [Related]
14. Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction.
Mahmood M; Lip GYH
Rev Esp Cardiol (Engl Ed); 2018 Oct; 71(10):847-855. PubMed ID: 29958809
[TBL] [Abstract][Full Text] [Related]
15. Discrepancies between the use of MDRD-4 IDMS and CKD-EPI equations, instead of the Cockcroft-Gault equation, in the determination of the dosage of direct oral anticoagulants in patients with non-valvular atrial fibrillation.
Pérez Cabeza AI; Chinchurreta Capote PA; González Correa JA; Ruiz Mateas F; Rosas Cervantes G; Rivas Ruiz F; Valle Alberca A; Bravo Marqués R
Med Clin (Barc); 2018 Feb; 150(3):85-91. PubMed ID: 28739270
[TBL] [Abstract][Full Text] [Related]
16. Oral Anticoagulation for Atrial Fibrillation Thromboembolism Prophylaxis in the Chronic Kidney Disease Population: the State of the Art in 2019.
Zhang L; Steckman DA; Adelstein EC; Schulman-Marcus J; Loka A; Mathew RO; Venditti FJ; Sidhu MS
Cardiovasc Drugs Ther; 2019 Aug; 33(4):481-488. PubMed ID: 31165356
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the predictive performance of bleeding risk scores in patients with non-valvular atrial fibrillation on oral anticoagulants.
Beshir SA; Aziz Z; Yap LB; Chee KH; Lo YL
J Clin Pharm Ther; 2018 Apr; 43(2):209-219. PubMed ID: 29030869
[TBL] [Abstract][Full Text] [Related]
18. Incidence of severe renal dysfunction among individuals taking warfarin and implications for non-vitamin K oral anticoagulants.
Fanola CL; Mooney D; Cowan AJ; Ko D; Sisson EK; Henault LE; Tripodis Y; Hylek EM
Am Heart J; 2017 Feb; 184():150-155. PubMed ID: 28224930
[TBL] [Abstract][Full Text] [Related]
19. Apixaban: Effective and Safe in Preventing Thromboembolic Events in Patients with Atrial Fibrillation and Renal Failure.
Cortese F; Scicchitano P; Gesualdo M; Ricci G; Carbonara S; Franchini C; Pia Schiavone BI; Corbo F; Ciccone MM
Curr Med Chem; 2017 Nov; 24(34):3813-3827. PubMed ID: 28820069
[TBL] [Abstract][Full Text] [Related]
20. Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study.
Başaran Ö; Dogan V; Beton O; Tekinalp M; Aykan AÇ; Kalaycıoğlu E; Bolat I; Taşar O; Şafak Ö; Kalçık M; Yaman M; İnci S; Altıntaş B; Kalkan S; Kırma C; Biteker M;
J Thromb Thrombolysis; 2017 Feb; 43(2):157-165. PubMed ID: 27848065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
